AtriCure, Inc. (NASDAQ:ATRC) had a loss and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company.
AtriCure, Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share were the same at $-0.10 in the quarter as EPS of $-0.10 in the year-earlier quarter.
Revenue: Rose 11.16% to $19.43 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: AtriCure, Inc. reported adjusted EPS loss of $0.10 per share. By that measure, the company beat the mean analyst estimate of $-0.11. It beat the average revenue estimate of $18.62 million.
Quoting Management: “Our first quarter results reflect double digit revenue growth, balanced globally. We are starting to see the results of our training and education efforts in capturing market share,” said Mike Carrel, President and Chief Executive Officer of AtriCure. Mr. Carrel continued, “We will continue to invest in transforming AtriCure into a commercially focused organization using training and clinical outcomes to accelerate revenue growth.”
Key Stats (on next page)…